ST. LOUIS, Feb. 7, 2012 /PRNewswire/ -- Centene Corporation
(NYSE: CNC) today announced its financial results for the quarter
and year ended December 31,
2011. As previously discussed, beginning with the fourth
quarter of 2011, we have reclassified certain medical costs to more
closely align with the NAIC definitions. All of the
information in this release has been reclassified to conform to the
current presentation. For additional information, the details of
the reclassification are provided in the supplemental financial
data of this release.
|
|
|
|
|
|
|
|
|
|
|
|
2011
Highlights
|
|
|
|
|
Q4
|
|
|
Full
Year
|
|
|
|
|
Premium and Service Revenues (in
millions)
|
$
|
1,458.5
|
|
|
$
|
5,181.0
|
|
|
|
|
Consolidated Health Benefits
Ratio
|
|
85.9
|
%
|
|
|
85.2
|
%
|
|
|
|
General & Administrative
expense ratio
|
|
11.0
|
%
|
|
|
11.3
|
%
|
|
|
|
Diluted EPS
|
$
|
0.57
|
|
|
$
|
2.12
|
(1)
|
|
|
|
Cash flow from operations (in
millions)
|
$
|
172.0
|
|
|
$
|
261.7
|
|
|
|
(1) Includes
$0.10 per share of debt extinguishment costs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fourth Quarter Highlights
- Quarter-end managed care at-risk membership of 1,816,000, an
increase of 18.4% year over year.
- Premium and Service Revenues of $1.5
billion, representing 29.1% year over year growth.
- Health Benefits Ratio of 85.9%, compared to 85.0% in the prior
year and 85.0% in the third quarter of 2011.
- General and Administrative expense ratio of 11.0%, compared to
11.3% in the prior year.
- Diluted earnings per share from continuing operations of
$0.57, an increase of 14.0% from the
prior year.
- Employees increased from 4,200 at December 31, 2010 to 5,300 at December 31, 2011, reflecting our continued
business expansions.
Other Events
- In January 2012, we were selected
to contract with the Washington Health Care Authority to serve
Medicaid beneficiaries in the state. Operations are expected
to commence in the third quarter of 2012.
- In February 2012, Louisiana
Healthcare Connections began operating under a new contract in
Louisiana to provide healthcare
services to Medicaid enrollees participating in the Bayou Health
program. In addition, Nurtur, our subsidiary which provides
life, health and wellness programs, commenced operations to provide
disease management services for state employees in Louisiana beginning in January 2012.
Michael F. Neidorff, Centene's
Chairman and Chief Executive Officer, stated, "During 2011, we were
able to successfully demonstrate our ability to grow through new
contract awards and expansions, while continuing to focus on our
targeted margins. I look forward to the new business
commencing in 2012 and the opportunity to develop additional
markets."
The following table depicts membership in Centene's managed care
organizations, by state:
|
|
|
|
December
31,
|
|
|
|
|
2011
|
|
2010
|
|
|
Arizona
|
|
23,700
|
|
22,400
|
|
|
Florida
|
|
198,300
|
|
194,900
|
|
|
Georgia
|
|
298,200
|
|
305,800
|
|
|
Illinois
|
|
16,300
|
|
-
|
|
|
Indiana
|
|
206,900
|
|
215,800
|
|
|
Kentucky
|
|
180,700
|
|
-
|
|
|
Massachusetts
|
|
35,700
|
|
36,200
|
|
|
Mississippi
|
|
31,600
|
|
-
|
|
|
Ohio
|
|
159,900
|
|
160,100
|
|
|
South Carolina
|
|
82,900
|
|
90,300
|
|
|
Texas
|
|
503,800
|
|
433,100
|
|
|
Wisconsin
|
|
78,000
|
|
74,900
|
|
|
Total at-risk
membership
|
|
1,816,000
|
|
1,533,500
|
|
|
Non-risk membership
|
|
4,900
|
|
4,200
|
|
|
Total
|
|
1,820,900
|
|
1,537,700
|
|
|
|
|
|
|
|
|
|
|
The following table depicts membership in Centene's managed care
organizations, by member category:
|
|
|
|
December
31,
|
|
|
|
2011
|
|
2010
|
|
Medicaid
|
|
1,336,800
|
|
1,177,100
|
|
CHIP & Foster
Care
|
|
213,900
|
|
210,500
|
|
ABD & Medicare
|
|
218,000
|
|
104,600
|
|
Hybrid Programs
|
|
40,500
|
|
36,200
|
|
Long-term Care
|
|
6,800
|
|
5,100
|
|
Total at-risk
membership
|
|
1,816,000
|
|
1,533,500
|
|
Non-risk membership
|
|
4,900
|
|
4,200
|
|
Total
|
|
1,820,900
|
|
1,537,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statement of Operations: Three Months Ended December 31, 2011
- For the fourth quarter of 2011, Premium and Service Revenues
increased 29.1% to $1.5 billion from
$1.1 billion in the fourth quarter of
2010. The increase was primarily driven by new operations in
Mississippi, Illinois and Kentucky added during 2011, Texas expansion and overall membership growth.
- Consolidated HBR of 85.9% for the fourth quarter of 2011
represents an increase of 0.9% from the comparable period in 2010
and from the third quarter of 2011. This increase is
primarily a result of the commencement of operations in
Kentucky in November 2011.
- Consolidated G&A expense ratio for the fourth quarter of
2011 was 11.0%, compared to 11.3% in the prior year. The
decrease is a result of leveraging our costs over higher revenues,
offset by additional business expansion costs.
- Earnings from operations increased to $47.4 million in the fourth quarter 2011 from
$45.5 million in the fourth quarter
2010. Net earnings from continuing operations were
$30.1 million in the fourth quarter
2011, compared to $25.5 million in
the fourth quarter of 2010.
- Earnings per diluted share increased to $0.57 in the fourth quarter of 2011 compared to
$0.50 in the prior year.
Statement of Operations: Year Ended December 31, 2011
- For the year ended December 31,
2011, Premium and Service Revenues increased 20.9% to
$5.2 billion from $4.3 billion in 2010. The increase was
driven by the commencement of operations in Mississippi, Kentucky and Illinois during 2011, Texas expansion and membership growth.
- Consolidated HBR of 85.2% for 2011 represents a decrease of
0.3% from 2010 primarily as a result of lower levels of utilization
and contract enhancements, partially offset by our Kentucky health plan which began operations in
November 2011.
- Consolidated G&A expense ratio for 2011 was 11.3%, compared
to 11.2% in the prior year. The increase is primarily due to
additional business expansion costs, offset by leveraging our
expenses over higher revenues.
- Earnings from operations increased to $190.3 million in 2011 from $157.1 million in 2010, or 21.2% year over year.
Net earnings from continuing operations were $111.2 million in 2011, compared to $90.9 million in 2010.
- Earnings per diluted share increased to $2.12 in 2011, including $(0.10) of debt extinguishment costs, compared to
$1.80 in the prior year.
Balance Sheet and Cash Flow
At December 31, 2011, the Company
had cash, investments and restricted deposits of $1,237.1 million, including $38.2 million held by its unregulated entities.
Medical claims liabilities totaled $608.0 million, representing 45.3 days in claims
payable. Total debt was $351.6
million and debt to capitalization was 22.6% at December 31, 2011 excluding the $77.8 million non-recourse mortgage note.
Cash flows from operations for the year ended December 31, 2011 were $261.7 million, or 2.4 times net earnings.
A reconciliation of the Company's change in days in claims
payable from the immediately preceding quarter-end is presented
below:
|
|
Days in claims payable,
September 30, 2011
|
43.6*
|
|
|
Impact of new
business
|
1.8
|
|
|
Ohio pharmacy carve
in
|
(0.8)
|
|
|
Timing of claim
payments
|
0.7
|
|
|
Days in claims payable, December
31, 2011
|
45.3
|
|
|
|
|
|
|
|
|
|
* Days in claims payable for September
30, 2011 have been reduced by 1.0 day to reflect the medical
cost reclassification.
Outlook
The table below depicts the Company's annual guidance for
2012:
|
|
|
|
Full Year
2012
|
|
|
|
|
Low
|
|
High
|
|
|
Premium and Service Revenues (in
millions)
|
|
$
7,200
|
|
$ 7,600
|
|
|
Diluted EPS
|
|
$
2.60
|
|
$ 2.80
|
|
|
Consolidated Health Benefits
Ratio
|
|
87.0%
|
|
88.0%
|
|
|
General & Administrative
expense ratio
|
|
9.5%
|
|
10.0%
|
|
|
|
|
|
|
|
|
|
Diluted Shares Outstanding (in
thousands)
|
|
53,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The above guidance has not been adjusted to include the impact
associated with the Washington RFP and assumes that the
Texas expansion will begin on
March 1 with required CMS approval of
premium rates.
Conference Call
As previously announced, the Company will host a conference call
Tuesday, February 7, 2012, at
8:30 A.M. (Eastern Time) to review
the financial results for the fourth quarter and year ended
December 31, 2011, and to discuss its
business outlook. Michael F.
Neidorff and William N.
Scheffel will host the conference call. Investors and
other interested parties are invited to listen to the conference
call by dialing 1-800-860-2442 in the U.S. and Canada; +1-412-858-4600 from abroad; or via a
live, audio webcast on the Company's website at www.centene.com,
under the Investors section. A webcast replay will be
available for on-demand listening shortly after the completion of
the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, February 12, 2013, at the aforementioned
URL. In addition, a digital audio playback will be available until
9:00 AM Eastern Time on Wednesday, February 15, 2012, by dialing
1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad,
and entering access code 10008192.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading
multi-line healthcare enterprise that provides programs and
related services to the rising number of under-insured and
uninsured individuals. Many receive benefits provided under
Medicaid, including the State Children's Health Insurance Program
(CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and long-term care, in addition to
other state-sponsored/hybrid programs, and Medicare (Special Needs
Plans). Centene's CeltiCare subsidiary offers states unique,
"exchange based" and other cost-effective coverage solutions for
low-income populations. The Company operates local health plans and
offers a range of health insurance solutions. It also contracts
with other healthcare and commercial organizations to provide
specialty services including behavioral health, life and health
management, managed vision, telehealth services, and pharmacy
benefits management.
The information provided in this press release contains
forward-looking statements that relate to future events and future
financial performance of Centene. Subsequent events and
developments may cause the Company's estimates to change. The
Company disclaims any obligation to update this forward-looking
financial information in the future. Readers are cautioned that
matters subject to forward-looking statements involve known and
unknown risks and uncertainties, including economic, regulatory,
competitive and other factors that may cause Centene's or its
industry's actual results, levels of activity, performance or
achievements to be materially different from any future results,
levels of activity, performance or achievements expressed or
implied by these forward-looking statements. Actual results may
differ from projections or estimates due to a variety of important
factors, including Centene's ability to accurately predict and
effectively manage health benefits and other operating expenses,
competition, membership and revenue projections, timing of
regulatory contract approval, changes in healthcare practices,
changes in federal or state laws or regulations, inflation,
provider contract changes, new technologies, reduction in provider
payments by governmental payors, major epidemics, disasters and
numerous other factors affecting the delivery and cost of
healthcare. The expiration, cancellation or suspension of Centene's
Medicaid Managed Care contracts by state governments would also
negatively affect Centene.
[Tables Follow]
CENTENE
CORPORATION AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(In
thousands, except share data)
(Unaudited)
|
|
|
|
December
31,
|
|
|
|
|
2011
|
|
2010
|
|
|
ASSETS
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
573,698
|
$
|
434,166
|
|
|
Premium and
related receivables, net of allowance for uncollectible accounts of
$639 and $17, respectively
|
|
|
157,450
|
|
136,243
|
|
|
Short-term investments, at
fair value (amortized cost $129,232 and $21,141,
respectively)
|
|
|
130,499
|
|
21,346
|
|
|
Other current
assets
|
|
|
78,363
|
|
65,066
|
|
|
Total current
assets
|
|
|
940,010
|
|
656,821
|
|
|
Long-term investments, at fair
value (amortized cost $497,805 and $585,862,
respectively)
|
|
|
506,140
|
|
595,879
|
|
|
Restricted deposits, at fair
value (amortized cost $26,751 and $22,755, respectively)
|
|
|
26,818
|
|
22,758
|
|
|
Property, software and
equipment, net of accumulated depreciation of $177,294 and
$138,629, respectively
|
|
|
349,622
|
|
326,341
|
|
|
Goodwill
|
|
|
281,981
|
|
278,051
|
|
|
Intangible assets,
net
|
|
|
27,430
|
|
29,109
|
|
|
Other long-term
assets
|
|
|
58,335
|
|
34,923
|
|
|
Total assets
|
|
$
|
2,190,336
|
$
|
1,943,882
|
|
|
LIABILITIES AND STOCKHOLDERS'
EQUITY
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
Medical claims
liability
|
|
$
|
607,985
|
$
|
456,765
|
|
|
Accounts payable and
accrued expenses
|
|
|
216,504
|
|
188,320
|
|
|
Unearned
revenue
|
|
|
9,890
|
|
117,344
|
|
|
Current portion of
long-term debt
|
|
|
3,234
|
|
2,817
|
|
|
Total current
liabilities
|
|
|
837,613
|
|
765,246
|
|
|
Long-term debt
|
|
|
348,344
|
|
327,824
|
|
|
Other long-term
liabilities
|
|
|
67,960
|
|
53,757
|
|
|
Total
liabilities
|
|
|
1,253,917
|
|
1,146,827
|
|
|
|
|
|
|
|
|
|
|
Commitments and
contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' equity:
|
|
|
|
|
|
|
|
Common stock, $.001 par
value; authorized 100,000,000 shares; 53,586,726 issued and
50,864,618 outstanding at December 31, 2011, and 52,172,037 issued
and 49,616,824 outstanding at December 31, 2010
|
|
|
54
|
|
52
|
|
|
Additional paid-in
capital
|
|
|
421,981
|
|
384,206
|
|
|
Accumulated other
comprehensive income:
|
|
|
|
|
|
|
|
Unrealized gain on
investments, net of tax
|
|
|
5,761
|
|
6,424
|
|
|
Retained
earnings
|
|
|
564,961
|
|
453,743
|
|
|
Treasury stock, at cost
(2,722,108 and 2,555,213 shares, respectively)
|
|
|
(57,123)
|
|
(50,486)
|
|
|
Total
Centene stockholders' equity
|
|
|
935,634
|
|
793,939
|
|
|
Noncontrolling
interest
|
|
|
785
|
|
3,116
|
|
|
Total stockholders'
equity
|
|
|
936,419
|
|
797,055
|
|
|
Total liabilities and
stockholders' equity
|
|
$
|
2,190,336
|
$
|
1,943,882
|
|
|
|
|
|
|
|
|
|
|
|
CENTENE
CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF OPERATIONS
(In
thousands, except share data)
(Unaudited)
|
|
|
Three Months
Ended
December
31,
|
|
Year
Ended
December
31,
|
|
|
|
2011
|
|
|
2010
|
|
2011
|
|
|
2010
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Premium
|
$
|
1,436,413
|
|
|
$
|
1,106,370
|
|
$
|
5,077,242
|
|
|
$
|
4,192,172
|
|
|
Service
|
|
22,136
|
|
|
|
23,118
|
|
|
103,765
|
|
|
|
91,661
|
|
|
Premium and
service revenues
|
|
1,458,549
|
|
|
|
1,129,488
|
|
|
5,181,007
|
|
|
|
4,283,833
|
|
|
Premium tax
|
|
48,627
|
|
|
|
51,481
|
|
|
159,575
|
|
|
|
164,490
|
|
|
Total
revenues
|
|
1,507,176
|
|
|
|
1,180,969
|
|
|
5,340,582
|
|
|
|
4,448,323
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical costs
|
|
1,233,739
|
|
|
|
940,935
|
|
|
4,324,746
|
|
|
|
3,584,452
|
|
|
Cost of services
|
|
17,397
|
|
|
|
16,414
|
|
|
78,114
|
|
|
|
63,919
|
|
|
General and administrative
expenses
|
|
159,937
|
|
|
|
127,886
|
|
|
587,004
|
|
|
|
477,765
|
|
|
Premium tax
|
|
48,726
|
|
|
|
50,233
|
|
|
160,394
|
|
|
|
165,118
|
|
|
Total
operating expenses
|
|
1,459,799
|
|
|
|
1,135,468
|
|
|
5,150,258
|
|
|
|
4,291,254
|
|
|
Earnings
from operations
|
|
47,377
|
|
|
|
45,501
|
|
|
190,324
|
|
|
|
157,069
|
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment and other
income
|
|
3,990
|
|
|
|
3,293
|
|
|
13,369
|
|
|
|
15,205
|
|
|
Debt extinguishment
costs
|
|
-
|
|
|
|
-
|
|
|
(8,488)
|
|
|
|
-
|
|
|
Interest expense
|
|
(4,797)
|
|
|
|
(5,452)
|
|
|
(20,320)
|
|
|
|
(17,992)
|
|
|
Earnings
from continuing operations, before income tax expense
|
|
46,570
|
|
|
|
43,342
|
|
|
174,885
|
|
|
|
154,282
|
|
|
Income tax
expense
|
|
17,306
|
|
|
|
16,958
|
|
|
66,522
|
|
|
|
59,900
|
|
|
Earnings
from continuing operations, net
of income tax expense
|
|
29,264
|
|
|
|
26,384
|
|
|
108,363
|
|
|
|
94,382
|
|
|
Discontinued operations, net of
income tax expense of $0, $12, $0 and $4,388,
respectively
|
|
-
|
|
|
|
(65)
|
|
|
-
|
|
|
|
3,889
|
|
|
Net
earnings
|
|
29,264
|
|
|
|
26,319
|
|
|
108,363
|
|
|
|
98,271
|
|
|
Noncontrolling
interest
|
|
(848)
|
|
|
|
920
|
|
|
(2,855)
|
|
|
|
3,435
|
|
|
Net earnings
attributable to Centene Corporation
|
$
|
30,112
|
|
|
$
|
25,399
|
|
$
|
111,218
|
|
|
$
|
94,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to Centene
Corporation common shareholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings from continuing
operations, net of income tax expense
|
$
|
30,112
|
|
|
$
|
25,464
|
|
$
|
111,218
|
|
|
$
|
90,947
|
|
|
Discontinued operations,
net of income tax (benefit) expense
|
|
-
|
|
|
|
(65)
|
|
|
-
|
|
|
|
3,889
|
|
|
Net earnings
|
$
|
30,112
|
|
|
$
|
25,399
|
|
$
|
111,218
|
|
|
$
|
94,836
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings per share
attributable to Centene Corporation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
$
|
0.60
|
|
|
$
|
0.52
|
|
$
|
2.22
|
|
|
$
|
1.87
|
|
|
Discontinued
operations
|
|
-
|
|
|
|
-
|
|
|
-
|
|
|
|
0.08
|
|
|
Earnings per
common share
|
$
|
0.60
|
|
|
$
|
0.52
|
|
$
|
2.22
|
|
|
$
|
1.95
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing
operations
|
$
|
0.57
|
|
|
$
|
0.50
|
|
$
|
2.12
|
|
|
$
|
1.80
|
|
|
Discontinued
operations
|
|
-
|
|
|
|
-
|
|
|
-
|
|
|
|
0.08
|
|
|
Earnings per
common share
|
$
|
0.57
|
|
|
$
|
0.50
|
|
$
|
2.12
|
|
|
$
|
1.88
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of
shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
50,522,726
|
|
|
|
49,356,768
|
|
|
50,198,954
|
|
|
|
48,754,947
|
|
|
Diluted
|
|
52,894,701
|
|
|
|
51,205,720
|
|
|
52,474,238
|
|
|
|
50,447,888
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CENTENE
CORPORATION AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In
thousands)
(Unaudited)
|
|
|
|
Year Ended
December 31,
|
|
|
|
|
2011
|
|
|
2010
|
|
|
Cash flows from operating
activities:
|
|
|
|
|
|
|
|
|
|
Net
earnings
|
|
$
|
108,363
|
|
|
$
|
98,271
|
|
|
Adjustments
to reconcile net earnings to net cash provided by operating
activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
58,327
|
|
|
|
52,000
|
|
|
Stock compensation
expense
|
|
|
18,171
|
|
|
|
13,874
|
|
|
Gain on sale of investments,
net
|
|
|
(287)
|
|
|
|
(6,337)
|
|
|
Debt extinguishment
costs
|
|
|
8,488
|
|
|
|
-
|
|
|
(Gain) on sale of UHP
|
|
|
-
|
|
|
|
(8,201)
|
|
|
Impairment loss on Casenet,
LLC
|
|
|
-
|
|
|
|
5,531
|
|
|
Deferred income taxes
|
|
|
2,031
|
|
|
|
10,317
|
|
|
Changes in
assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Premium and related
receivables
|
|
|
(11,306)
|
|
|
|
(23,359)
|
|
|
Other current assets
|
|
|
(11,812)
|
|
|
|
(3,240)
|
|
|
Other assets
|
|
|
(2)
|
|
|
|
(2,028)
|
|
|
Medical claims
liability
|
|
|
149,756
|
|
|
|
(30,421)
|
|
|
Unearned revenue
|
|
|
(109,082)
|
|
|
|
25,700
|
|
|
Accounts payable and accrued
expenses
|
|
|
38,889
|
|
|
|
37,398
|
|
|
Other operating
activities
|
|
|
10,160
|
|
|
|
(573)
|
|
|
Net cash
provided by operating activities
|
|
|
261,696
|
|
|
|
168,932
|
|
|
Cash flows from investing
activities:
|
|
|
|
|
|
|
|
|
|
Capital
expenditures
|
|
|
(68,993)
|
|
|
|
(63,304)
|
|
|
Capital
expenditures of Centene Center LLC
|
|
|
(4,715)
|
|
|
|
(55,252)
|
|
|
Purchase of
investments
|
|
|
(318,397)
|
|
|
|
(615,506)
|
|
|
Sales and
maturities of investments
|
|
|
267,404
|
|
|
|
570,423
|
|
|
Proceeds
from asset sales
|
|
|
-
|
|
|
|
13,420
|
|
|
Investments
in acquisitions, net of cash acquired, and investment in equity
method investee
|
|
|
(4,375)
|
|
|
|
(60,388)
|
|
|
Net cash
used in investing activities
|
|
|
(129,076)
|
|
|
|
(210,607)
|
|
|
Cash flows from financing
activities:
|
|
|
|
|
|
|
|
|
|
Proceeds
from exercise of stock options
|
|
|
15,815
|
|
|
|
3,419
|
|
|
Proceeds
from borrowings
|
|
|
419,183
|
|
|
|
218,538
|
|
|
Proceeds
from stock offering
|
|
|
-
|
|
|
|
104,534
|
|
|
Payment of
long-term debt
|
|
|
(416,283)
|
|
|
|
(195,728)
|
|
|
Purchase of
noncontrolling interest
|
|
|
-
|
|
|
|
(48,257)
|
|
|
Distributions from (to)
noncontrolling interest
|
|
|
813
|
|
|
|
(7,387)
|
|
|
Excess tax
benefits from stock compensation
|
|
|
4,435
|
|
|
|
963
|
|
|
Common stock
repurchases
|
|
|
(7,809)
|
|
|
|
(3,224)
|
|
|
Debt issue
costs
|
|
|
(9,242)
|
|
|
|
(769)
|
|
|
Net cash
provided by financing activities
|
|
|
6,912
|
|
|
|
72,089
|
|
|
Net increase
in cash and cash equivalents
|
|
|
139,532
|
|
|
|
30,414
|
|
|
Cash and cash
equivalents, beginning of period
|
|
|
434,166
|
|
|
|
403,752
|
|
|
Cash and cash
equivalents, end of period
|
|
$
|
573,698
|
|
|
$
|
434,166
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash
flow information:
|
|
|
|
|
|
|
|
|
|
Interest
paid
|
|
$
|
27,383
|
|
|
$
|
17,296
|
|
|
Income taxes
paid
|
|
$
|
50,444
|
|
|
$
|
53,938
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure of
non-cash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
Contribution
from noncontrolling interest
|
|
$
|
-
|
|
|
$
|
306
|
|
|
Capital
expenditures
|
|
$
|
6,591
|
|
|
$
|
8,720
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CENTENE
CORPORATION
CONTINUING
OPERATIONS SUPPLEMENTAL FINANCIAL DATA
|
|
|
Q4
|
|
Q3
|
|
Q2
|
|
Q1
|
|
Q4
|
|
|
2011
|
|
2011
|
|
2011
|
|
2011
|
|
2010
|
|
MEMBERSHIP
|
|
|
|
|
|
|
|
|
|
|
Managed Care:
|
|
|
|
|
|
|
|
|
|
|
Arizona
|
23,700
|
|
22,800
|
|
22,800
|
|
22,600
|
|
22,400
|
|
Florida
|
198,300
|
|
188,600
|
|
190,600
|
|
188,800
|
|
194,900
|
|
Georgia
|
298,200
|
|
298,000
|
|
303,100
|
|
303,300
|
|
305,800
|
|
Illinois
|
16,300
|
|
13,600
|
|
700
|
|
-
|
|
-
|
|
Indiana
|
206,900
|
|
205,300
|
|
206,700
|
|
209,400
|
|
215,800
|
|
Kentucky
|
180,700
|
|
-
|
|
-
|
|
-
|
|
-
|
|
Massachusetts
|
35,700
|
|
34,700
|
|
32,900
|
|
34,100
|
|
36,200
|
|
Mississippi
|
31,600
|
|
30,600
|
|
30,800
|
|
-
|
|
-
|
|
Ohio
|
159,900
|
|
162,200
|
|
159,900
|
|
160,900
|
|
160,100
|
|
South Carolina
|
82,900
|
|
86,500
|
|
82,800
|
|
84,900
|
|
90,300
|
|
Texas
|
503,800
|
|
494,500
|
|
470,400
|
|
456,700
|
|
433,100
|
|
Wisconsin
|
78,000
|
|
78,900
|
|
79,800
|
|
81,800
|
|
74,900
|
|
Total at-risk
membership
|
1,816,000
|
|
1,615,700
|
|
1,580,500
|
|
1,542,500
|
|
1,533,500
|
|
Non-risk
membership
|
4,900
|
|
10,600
|
|
10,400
|
|
10,400
|
|
4,200
|
|
TOTAL
|
1,820,900
|
|
1,626,300
|
|
1,590,900
|
|
1,552,900
|
|
1,537,700
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicaid
|
1,336,800
|
|
1,189,900
|
|
1,172,400
|
|
1,169,700
|
|
1,177,100
|
|
CHIP & Foster
Care
|
213,900
|
|
210,600
|
|
211,400
|
|
208,900
|
|
210,500
|
|
ABD &
Medicare
|
218,000
|
|
171,700
|
|
156,300
|
|
123,800
|
|
104,600
|
|
Hybrid Programs
|
40,500
|
|
38,400
|
|
35,500
|
|
35,200
|
|
36,200
|
|
Long-term Care
|
6,800
|
|
5,100
|
|
4,900
|
|
4,900
|
|
5,100
|
|
Total at-risk
membership
|
1,816,000
|
|
1,615,700
|
|
1,580,500
|
|
1,542,500
|
|
1,533,500
|
|
Non-risk
membership
|
4,900
|
|
10,600
|
|
10,400
|
|
10,400
|
|
4,200
|
|
TOTAL
|
1,820,900
|
|
1,626,300
|
|
1,590,900
|
|
1,552,900
|
|
1,537,700
|
|
|
|
|
|
|
|
|
|
|
|
|
Specialty
Services(a):
|
|
|
|
|
|
|
|
|
|
|
Cenpatico Behavioral
Health
|
|
|
|
|
|
|
|
|
|
|
Arizona
|
168,900
|
|
175,500
|
|
173,200
|
|
172,700
|
|
174,600
|
|
Kansas
|
46,200
|
|
45,600
|
|
45,000
|
|
44,000
|
|
39,200
|
|
TOTAL
|
215,100
|
|
221,100
|
|
218,200
|
|
216,700
|
|
213,800
|
|
|
|
|
|
|
|
|
|
|
|
|
(a) Includes
external membership only.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
REVENUE PER MEMBER PER
MONTH(b)
|
$
|
261.95
|
|
$
|
245.27
|
|
$
|
240.57
|
|
$
|
238.31
|
|
$
|
239.66
|
|
|
|
|
|
|
|
|
|
|
|
|
CLAIMS(b)
|
|
|
|
|
|
|
|
|
|
|
Period-end
inventory
|
495,500
|
|
482,900
|
|
415,700
|
|
527,100
|
|
434,900
|
|
Average
inventory
|
367,590
|
|
312,400
|
|
332,300
|
|
347,900
|
|
304,700
|
|
Period-end inventory per
member
|
0.27
|
|
0.30
|
|
0.26
|
|
0.34
|
|
0.28
|
|
(b) Revenue per member and
claims information are presented for the Managed Care at-risk
members.
|
|
|
|
|
|
|
|
|
|
|
|
|
NUMBER OF
EMPLOYEES
|
5,300
|
|
5,000
|
|
4,800
|
|
4,500
|
|
4,200
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Q4
|
|
Q3
|
|
Q2
|
|
Q1
|
|
Q4
|
|
|
2011
|
|
2011
|
|
2011
|
|
2011
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
|
|
DAYS IN CLAIMS
PAYABLE (c)
|
45.3
|
|
43.6
|
|
43.4
|
|
43.4
|
|
44.7
|
|
(c) Days in Claims Payable is a
calculation of Medical Claims Liabilities at the end of the period
divided by average claims expense per calendar day for such period.
|
|
|
|
CASH AND INVESTMENTS (in
millions)
|
|
|
|
|
|
|
|
|
|
Regulated
|
$
|
1,198.9
|
|
$
|
1,079.3
|
|
$
|
1,061.9
|
|
$
|
1,096.3
|
|
$
|
1,043.0
|
|
Unregulated
|
|
38.2
|
|
|
35.9
|
|
|
36.5
|
|
|
31.7
|
|
|
30.9
|
|
TOTAL
|
$
|
1,237.1
|
|
$
|
1,115.2
|
|
$
|
1,098.4
|
|
$
|
1,128.0
|
|
$
|
1,073.9
|
|
|
|
|
|
|
|
|
|
|
|
|
DEBT TO
CAPITALIZATION
|
27.3%
|
|
28.0%
|
|
28.1%
|
|
26.9%
|
|
29.3%
|
|
DEBT TO CAPITALIZATION EXCLUDING
NON-RECOURSE DEBT(d)
|
22.6%
|
|
23.2%
|
|
23.0%
|
|
21.4%
|
|
23.9%
|
|
Debt to Capitalization is
calculated as follows: total debt divided by (total
debt + total equity).
(d) The non-recourse debt
represents our mortgage note payable ($77.8 million at December 31,
2011).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL COST / GENERAL AND
ADMINISTRATIVE EXPENSE RECLASSIFICATION IMPACT ($ in
thousands):
|
|
|
Three Months
Ended December 31,
|
|
Year Ended
December 31,
|
|
|
2011
|
|
2010
|
|
2011
|
|
2010
|
|
|
Medical
Costs
|
|
HBR
|
|
Medical
Costs
|
|
HBR
|
|
Medical
Costs
|
|
HBR
|
|
Medical
Costs
|
|
HBR
|
|
Historical
|
$1,206,516
|
|
84.0%
|
|
$922,070
|
|
83.3%
|
|
$4,227,916
|
|
83.3%
|
|
$3,514,394
|
|
83.8%
|
|
Reclassification
impact
|
27,223
|
|
1.9
|
|
18,865
|
|
1.7
|
|
96,830
|
|
1.9
|
|
70,058
|
|
1.7
|
|
Revised
|
$1,233,739
|
|
85.9%
|
|
$940,935
|
|
85.0%
|
|
$4,324,746
|
|
85.2%
|
|
$3,584,452
|
|
85.5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended December 31,
|
|
Year Ended
December 31,
|
|
|
2011
|
|
2010
|
|
2011
|
|
2010
|
|
|
G&A
Expense
|
|
G&A
Ratio
|
|
G&A
Expense
|
|
G&A
Ratio
|
|
G&A
Expense
|
|
G&A
Ratio
|
|
G&A
Expense
|
|
G&A
Ratio
|
|
Historical
|
$187,160
|
|
12.8%
|
|
$146,751
|
|
13.0%
|
|
$683,834
|
|
13.2%
|
|
$547,823
|
|
12.8%
|
|
Reclassification
impact
|
(27,223)
|
|
(1.8)
|
|
(18,865)
|
|
(1.7)
|
|
(96,830)
|
|
(1.9)
|
|
(70,058)
|
|
(1.6)
|
|
Revised
|
$159,937
|
|
11.0%
|
|
$127,886
|
|
11.3%
|
|
$587,004
|
|
11.3%
|
|
$477,765
|
|
11.2%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Ratios:
|
|
|
Three Months
Ended
December
31,
|
|
Year
Ended
December
31,
|
|
|
2011
|
|
|
2010
|
|
2011
|
|
|
2010
|
|
Health Benefits
Ratios:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicaid and
CHIP
|
82.9
|
%
|
|
|
83.7
|
%
|
|
82.4
|
%
|
|
|
85.0
|
%
|
|
ABD and
Medicare
|
88.8
|
|
|
|
89.1
|
|
|
89.8
|
|
|
|
87.1
|
|
|
Specialty
Services
|
94.0
|
|
|
|
86.1
|
|
|
89.1
|
|
|
|
86.2
|
|
|
Total
|
85.9
|
|
|
|
85.0
|
|
|
85.2
|
|
|
|
85.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total General &
Administrative Expense Ratio
|
11.0
|
%
|
|
|
11.3
|
%
|
|
11.3
|
%
|
|
|
11.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MEDICAL CLAIMS LIABILITY (In thousands)
The changes in medical claims liability are summarized as
follows:
|
|
Balance,
December 31, 2010
|
$
|
456,765
|
|
|
|
|
|
Incurred related
to:
|
|
|
|
|
|
|
|
Current period
|
|
4,390,123
|
|
|
|
|
|
Prior period
|
|
(65,377)
|
|
|
|
|
|
Total incurred
|
|
4,324,746
|
|
|
|
|
|
Paid related
to:
|
|
|
|
|
|
|
|
Current period
|
|
3,788,808
|
|
|
|
|
|
Prior period
|
|
384,718
|
|
|
|
|
|
Total paid
|
|
4,173,526
|
|
|
|
|
|
Balance,
December 31, 2011
|
$
|
607,985
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Centene's claims reserving process utilizes a consistent
actuarial methodology to estimate Centene's ultimate liability.
Any reduction in the "Incurred related to: Prior
period" amount may be offset as Centene actuarially determines
"Incurred related to: Current period." As such, only in the
absence of a consistent reserving methodology would favorable
development of prior period claims liability estimates reduce
medical costs. Centene believes it has consistently applied
its claims reserving methodology in each of the periods
presented.
The amount of the "Incurred related to: Prior period" above
represents favorable development and includes the effects of
reserving under moderately adverse conditions, new markets where we
use a conservative approach in setting reserves during the initial
periods of operations, receipts from other third party payors
related to coordination of benefits and lower medical utilization
and cost trends for dates of service prior to December 31, 2010.
SOURCE Centene Corporation